EGFR and cancer: In support of this idea, several cancer cells overexpress EGFR-stabilizing proteins, such as Sortilin, TRIB3, and USP22, which suppress EGFR degradation, and their knockdown inhibits cancer cell proliferation (24, 25, 26).